JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4876
NWPX Infrastructure Inc
NWPX
$1.02B
| $66K | ﹤0.01% |
2,628
+298
| +13% | +$7.39K |
2017 Q4
6 quarters
|
|
4877
Invesco Dividend Achievers ETF
PFM
$778M
| $66K | ﹤0.01% |
+2,311
| New | +$65K |
2019 Q2
0 quarters
|
|
4878
Construction Partners
ROAD
$5.14B
| $66K | ﹤0.01% |
+4,643
| New | +$60.6K |
2019 Q2
0 quarters
|
|
|
WAAS
4879
DELISTED
AquaVenture Holdings Limited
WAAS
| $66K | ﹤0.01% |
3,273
+613
| +23% | +$11.7K |
2016 Q4
10 quarters
|
|
|
GDEN
4880
DELISTED
Golden Entertainment
GDEN
| $65K | ﹤0.01% |
4,698
+187
| +4% | +$2.72K |
2017 Q4
6 quarters
|
|
4881
Limbach Holdings
LMB
$596M
| $65K | ﹤0.01% |
7,900
+6,900
| +690% | +$60K |
2018 Q4
2 quarters
|
|
4882
Marker Therapeutics
MRKR
$17.7M
| $65K | ﹤0.01% |
+844
| New | +$50.1K |
2019 Q2
0 quarters
|
|
|
XXII
4883
22nd Century Group
XXII
$651K
| – | – |
0
| – | – |
2018 Q2
4 quarters
|
|
|
ZEUS
4884
DELISTED
Olympic Steel
ZEUS
| $65K | ﹤0.01% |
4,825
+917
| +23% | +$13.6K |
2016 Q1
13 quarters
|
|
|
SFE
4885
DELISTED
Safeguard Scientifics, Inc.
SFE
| $65K | ﹤0.01% |
5,354
-6,698
| -56% | -$78.4K |
2013 Q2
24 quarters
|
|
|
AVDL
4886
DELISTED
Avadel Pharmaceuticals
AVDL
| $64K | ﹤0.01% |
22,700
+18,000
| +383% | +$30.9K |
2018 Q2
4 quarters
|
|
4887
Lifecore Biomedical
LFCR
$247M
| $64K | ﹤0.01% |
6,714
+776
| +13% | +$7.83K |
2017 Q4
6 quarters
|
|
|
RBNC
4888
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $64K | ﹤0.01% |
2,805
+340
| +14% | +$7.61K |
2017 Q4
6 quarters
|
|
4889
BayCom
BCML
$339M
| $63K | ﹤0.01% |
2,848
+351
| +14% | +$8.01K |
2018 Q2
4 quarters
|
|
4890
FVCBankcorp
FVCB
$319M
| $63K | ﹤0.01% |
4,166
+3,555
| +582% | +$49.5K |
2018 Q4
2 quarters
|
|
4891
CALL
Howmet Aerospace
HWM
$91.6B
| $63K | ﹤0.01% |
+3,260
| New | +$55K |
2019 Q2
0 quarters
|
|
|
4892
PUT
Howmet Aerospace
HWM
$91.6B
| $63K | ﹤0.01% |
+3,260
| New | +$55K |
2019 Q2
0 quarters
|
|
4893
Invesco S&P International Developed Low Volatility ETF
IDLV
$317M
| $63K | ﹤0.01% |
1,857
| – | – |
2017 Q4
6 quarters
|
|
|
PTN
4894
Palatin Technologies
PTN
$16.9M
| $63K | ﹤0.01% |
45
+5
| +13% | +$7.87K |
2018 Q1
5 quarters
|
|
4895
NYLIM FTSE International Equity Currency Neutral ETF
HFXI
$2.34B
| $62K | ﹤0.01% |
+3,047
| New | +$61.7K |
2019 Q2
0 quarters
|
|
4896
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.94B
| $62K | ﹤0.01% |
1,539
| – | – |
2018 Q3
3 quarters
|
|
|
GHL
4897
DELISTED
Greenhill & Co., Inc.
GHL
| $62K | ﹤0.01% |
4,619
-86,316
| -95% | -$1.58M |
2013 Q2
24 quarters
|
|
|
ELOX
4898
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $62K | ﹤0.01% |
156
+19
| +14% | +$8K |
2018 Q2
4 quarters
|
|
|
FGP
4899
DELISTED
Ferrellgas Partners, L.P.
FGP
| $62K | ﹤0.01% |
64,252
+63,540
| +8,924% | +$74.7K |
2013 Q2
24 quarters
|
|
4900
First Trust SSI Strategic Convertible Securities ETF
FCVT
$97M
| $61K | ﹤0.01% |
1,959
| – | – |
2016 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.